![]() |
Volumn 5, Issue 5, 2006, Pages 162-166
|
Pharmacology of drugs used in the treatment of mood disorders
|
Author keywords
anticonvulsant; antidepressant; atypical antipsychotic; bipolar disorder; depression; mania resistant depression; mood disorder; mood stabiliser; noradrenaline; serotonin (5 HT); SNRI; SSRI
|
Indexed keywords
AGOMELATINE;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
AMFEBUTAMONE;
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
CARBAMAZEPINE;
DULOXETINE;
LAMOTRIGINE;
LITHIUM;
MIFEPRISTONE;
MIRTAZAPINE;
MOCLOBEMIDE;
MONOAMINE;
MONOAMINE OXIDASE INHIBITOR;
NEUROLEPTIC AGENT;
NORADRENALIN;
NORADRENALIN UPTAKE INHIBITOR;
PHENELZINE;
PINDOLOL;
REBOXETINE;
SEROTONIN;
SEROTONIN UPTAKE INHIBITOR;
TRANYLCYPROMINE;
TRAZODONE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VALPROIC ACID;
VENLAFAXINE;
AGITATION;
ANTICHOLINERGIC EFFECT;
ARTICLE;
BIPOLAR DISORDER;
CLINICAL TRIAL;
DROWSINESS;
DRUG MECHANISM;
DRUG TOLERABILITY;
DYSTHYMIA;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
MAJOR DEPRESSION;
MANIA;
MOOD DISORDER;
NEUROTRANSMISSION;
NORADRENALIN RELEASE;
PRIORITY JOURNAL;
RECEPTOR OCCUPANCY;
SEDATION;
SIDE EFFECT;
WEIGHT GAIN;
|
EID: 33846176065
PISSN: 14761793
EISSN: None
Source Type: Journal
DOI: 10.1383/psyt.2006.5.5.162 Document Type: Article |
Times cited : (5)
|
References (5)
|